Eris Lifesciences Ltd vs Makers Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of ERIS Lifesciences Ltd is ₹ 1357 as of 05 May 15:30 . The P/E Ratio of ERIS Lifesciences Ltd changed from 23.1 on March 2021 to 54.8 on March 2025 . This represents a CAGR of 18.86% over 5 yearsThe P/E Ratio of Makers Laboratories Ltd changed from 18 on March 2022 to 10.2 on March 2025 . This represents a CAGR of -13.24% over 4 years The Market Cap of ERIS Lifesciences Ltd changed from ₹ 8207 crore on March 2021 to ₹ 19287 crore on March 2025 . This represents a CAGR of 18.64% over 5 yearsThe Market Cap of Makers Laboratories Ltd changed from ₹ 117.71 crore on March 2021 to ₹ 76.11 crore on March 2025 . This represents a CAGR of -8.35% over 5 years The revenue of ERIS Lifesciences Ltd for the Dec '25 is ₹ 807.59 crore as compare to the Sep '25 revenue of ₹ 795.5 crore. This represent the growth of 1.52% The revenue of Makers Laboratories Ltd for the Dec '25 is ₹ 35.99 crore as compare to the Sep '25 revenue of ₹ 34.53 crore. This represent the growth of 4.23% The ebitda of ERIS Lifesciences Ltd for the Dec '25 is ₹ 264.51 crore as compare to the Sep '25 ebitda of ₹ 291.3 crore. This represent the decline of -9.2% The ebitda of Makers Laboratories Ltd for the Dec '25 is ₹ 4.49 crore as compare to the Sep '25 ebitda of ₹ 2.64 crore. This represent the growth of 70.08% The net profit of ERIS Lifesciences Ltd changed from ₹ 89.55 crore to ₹ 108.83 crore over 7 quarters. This represents a CAGR of 11.79% The net profit of Makers Laboratories Ltd changed from ₹ -0.7 crore to ₹ 2.27 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of ERIS Lifesciences Ltd changed from 21.3 % on March 2021 to 129.35 % on March 2025 . This represents a CAGR of 43.44% over 5 yearsThe Dividend Payout of Makers Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About ERIS Lifesciences Ltd

Eris Lifesciences Limited was incorporated on January 25, 2007.
Subsequently, the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9, 2007.
Further, the Company was converted into a Public Limited cCompany and the name was changed to 'Eris Lifesciences Limited' on February 2, 2017.
The Company has a manufacturing plant in Guwahati, Assam and is presently engaged in manufacturing and marketing of pharmaceutical products.
It has presence in high growth chronic, sub chronic and acute therapeutic areas that require high intervention of specialist and super specialist doctors. The company develops, manufactures and commercializes branded pharmaceutical products in selected therapeutic areas within chronic and acute categories of the Indian Pharmaceutical Market (IPM), such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infective.

About Makers Laboratories Ltd

Makers Laboratores Limited (MLL) was incorporated in the State of Maharashtra, which commenced business from 21st July, 1984.
The Company was promoted by Satish Kumar Gupta and Naval Tated.
The Company is presently in manufacture of pharmaceutical formulations and drug intermediates. Makers Drugs & Food Products Ltd. (MDFP) was amalgamated with the Company with effect from 1st April 1993.
As per terms of the scheme of amalgamation, the Company allotted 3,02,700 equity shares of the company fully paid, to the members of MDFPL in the ratio of 2 equity shares for every 1 equity share held by them in MDFPL. During 1996-97, MLL enhanced its installed capacity of Tablets/Capsules from 3000 to 3175 lacs and Oral/Liquids/Dry Syrups from 420000 to 500000 Ltrs and Ointments/Creams/External Liquids from 107000 to 120000 Kgs/Lit.

FAQs for the comparison of ERIS Lifesciences Ltd and Makers Laboratories Ltd

Which company has a larger market capitalization, ERIS Lifesciences Ltd or Makers Laboratories Ltd?

Market cap of ERIS Lifesciences Ltd is 18,759 Cr while Market cap of Makers Laboratories Ltd is 86 Cr

What are the key factors driving the stock performance of ERIS Lifesciences Ltd and Makers Laboratories Ltd?

The stock performance of ERIS Lifesciences Ltd and Makers Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for ERIS Lifesciences Ltd and Makers Laboratories Ltd?

As of May 5, 2026, the ERIS Lifesciences Ltd stock price is INR ₹1354.05. On the other hand, Makers Laboratories Ltd stock price is INR ₹147.1.

How do dividend payouts of ERIS Lifesciences Ltd and Makers Laboratories Ltd compare?

To compare the dividend payouts of ERIS Lifesciences Ltd and Makers Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.